Company Profiles

driven by the PitchBook Platform

acousia Therapeutics

acousia Therapeutics
2012 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$2.64M LATEST DEAL AMOUNT
$2.64M TOTAL AMOUNT RAISED
2 INVESTORS
Description

Provider and developer of therapeutics to prevent hearing loss. The company develops therapeutics to replace lost sensory hair cells, the key cells for hearing in the inner ear, by cellular regeneration originating from supporting cells.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
Sindelfinger Straße 3
72070 Tübingen
Germany
+49 (0)70 7129 8818 6
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore acousia Therapeutics’s full profile, request a free trial.

acousia Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 14-Dec-2016 $2.64M $2.64M Completed Startup
1. Early Stage VC 01-Jan-2012 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

acousia Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Axxam Corporation Minority 000 0000 000000 0
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority 000 0000 000000 0

acousia Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Bös Ph.D Chief Executive Officer
Karl-Heinz Wiesmuller Co-Founder

acousia Therapeutics Board Members (3)

Name Representing Role Since Contact
Info
Frank Kalkbrenner MD Boehringer Ingelheim Board Member 000 0000
Hubert Lowenheim MD acousia Therapeutics Co-Founder & Board Member 000 0000
Stefan Lohmer Ph.D Axxam Board Member 000 0000